Advances in either phospholipids treatment of cancer

Intravitreally injected platelet activating factor induces retinitis in experimental animals.

Current eye research·1999

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies.

European urology·1998

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils.

Prostaglandins, leukotrienes, and essential fatty acids·1997

The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis.

Gastroenterology·1996

Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat.

Pharmacological research·1996

A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice.

Nuclear medicine and biology·1996

Spatial Heterogeneity in Anaplastic Thyroid Carcinoma: Mechanistic Insights and Clinical Translation through Single-Cell and Spatial Transcriptomics.

Critical reviews in oncology/hematology·2026

Predictive biomarkers in cancer immunotherapy for genitourinary malignancies.

Critical reviews in oncology/hematology·2026

The Double-Edged Sword of PD‑1/PD‑L1 Blockade: Bridging Hepatocellular Carcinoma to Liver Transplantation While Minimizing Allograft Injury.

Critical reviews in oncology/hematology·2026

Cytokine‑driven modulation of immune checkpoint therapy response in colorectal cancer.

Critical reviews in oncology/hematology·2026

Interaction Between Lactic Acid and Gliomas in the Tumor Microenvironment: Potential Targets for Glioma Therapy.

Critical reviews in oncology/hematology·2026

From cellular therapy to biologics: Non-viral delivery strategies for in vivo CAR-T engineering.

Critical reviews in oncology/hematology·2026

Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

European journal of nuclear medicine and molecular imaging·2026

Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.

Gut·2026

Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

Journal of Crohn's & colitis·2026

Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance.

Biochimica et biophysica acta. Reviews on cancer·2026

Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.

Biochimica et biophysica acta. Reviews on cancer·2026

Related Experiment Videos

Advances in either phospholipids treatment of cancer

Related Concept Videos

Intravitreally injected platelet activating factor induces retinitis in experimental animals.

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies.

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils.

The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis.

Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat.

A distribution study of 11C platelet-activating factor (PAF) analogs in normal and tumor-bearing mice.

Spatial Heterogeneity in Anaplastic Thyroid Carcinoma: Mechanistic Insights and Clinical Translation through Single-Cell and Spatial Transcriptomics.

Predictive biomarkers in cancer immunotherapy for genitourinary malignancies.

The Double-Edged Sword of PD‑1/PD‑L1 Blockade: Bridging Hepatocellular Carcinoma to Liver Transplantation While Minimizing Allograft Injury.

Cytokine‑driven modulation of immune checkpoint therapy response in colorectal cancer.

Interaction Between Lactic Acid and Gliomas in the Tumor Microenvironment: Potential Targets for Glioma Therapy.

From cellular therapy to biologics: Non-viral delivery strategies for in vivo CAR-T engineering.

Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.

Radiopharmaceutical Combination Therapies in Advanced Prostate Cancer.

Heterozygous germline mutations in MSH3, and probably MLH3, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk.

Bridging preclinical and clinical efficacy of SIK2/SIK3 inhibition in inflammatory bowel disease through integrated murine, patient-derived models, and phase 2a trial-based analyses.

Engineered nano-delivery platforms targeting ferroptosis-evasion pathways to reverse tumor drug resistance.

Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.

Related Experiment Videos

Advances in either phospholipids treatment of cancer

Related Concept Videos

Related Articles